Vanchin, Byambasuren
Loading...
Товч нэр
Vanchin, Byambasuren
Бүтэн нэр
Vanchin Byambasuren
Латин нэр
Vanchin Byambasuren
Албан тушаал
Судлаач
ORCID
Scopus Author ID
9 results
Now showing 1 - 9 of 9
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Burdens of Non-Communicable Disease, Cancer and Cardio-Oncology in Mongolia.(Mongolian National University of Medical Sciences, 2019-04-22); ; ; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Association between NT- pro BNP and Cardio-metabolic Risk Factors in Mongolians(2021-07-30); ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Screening, Awareness, Treatment, and Control of Dyslipidemia Among Adults in Ulaanbaatar, Mongolia(Mongolian National University of Medical Sciences, 2019-12-29); ; ; Objective: The prevalence of dyslipidemia continues to increase in recent decades in Mongolia; however, little is known about awareness, treatment, and control of dyslipidemia. The aim of this study was to assess the awareness, treatment, and control of dyslipidemia in adults in Ulaanbaatar, Mongolia. Methods: This cross-sectional study was conducted between June 2017 and March 2018. A total of 326 people in Ulaanbaatar participated in this study. Results: Out of the 326 participants, 224 (68.7%, 64.9 in females; 75% in males) had dyslipidemia, and around the one third 113 (34,7%) were aware of the condition. Out of the 224 dyslipidemia individuals, only 27 (8.3%) were on statin treatment. Among those individuals receiving treatment, 19 (70.4%) serum lipid level was under the desired level. Conclusion: Our study revealed an alarmingly high prevalence of dyslipidemia, low level of awareness, insufficient treatment, yet a comparatively high level of control of dyslipidemia among the adults aged 20- 69 in Ulaanbaatar relative to some other countries. The awareness, treatment, and control of dyslipidemia in the rural parts of Mongolia are unknown. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Cardiac Fibrosis: Only from Resident Cardiac Fibroblasts?(Mongolian National University of Medical Sciences, 2019-09-25); ; ; - Some of the metrics are blocked by yourconsent settings
Item type:Publication, H3K27Me3 abundance is associated with a decreased barrier function of endothelial cells by directly silencing VE-cadherin expression.(2025-07); Scopus© Citations 7 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Myocardial tissue changes detected by cardiac MRI in a patient with suspected systemic sarcoidosis.(2023-03); Scopus© Citations 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Reciprocal regulation of endothelial-mesenchymal transition by MAPK7 and EZH2 in intimal hyperplasia and coronary artery disease.(2021-09); Scopus© Citations 16 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The Endothelium as a Target for Anti-Atherogenic Therapy: A Focus on the Epigenetic Enzymes EZH2 and SIRT1.(2021-02); Scopus© Citations 30 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey(Elsevier BV, 2021-12); ; ; BACKGROUND: With the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020, Mongolia implemented rapid emergency measures and did not report local transmission until November 2020. We conducted a national seroprevalence survey to monitor the burden of SARS-CoV-2 in Mongolia in the months surrounding the first local transmission. METHODS: During October-December 2020, participants were randomly selected using age stratification and invited for interviews and blood samples at local primary health centres. We screened for total SARS-CoV-2 antibodies, followed by two-step quantitative SARS-CoV-2 IgG serology tests for positive samples. Weighted and test-adjusted seroprevalences were estimated. We used chi-square, Fisher's exact and other tests to identify variables associated with seropositivity. FINDINGS: A total of 5000 subjects were enrolled. We detected SARS-CoV-2 IgG antibodies in 72 samples. Crude seroprevalence of SARS-CoV-2 antibodies was 1·44% (95%CI,1·21-1·67). Population weighted and test-adjusted seroprevalences were 1·36% (95%CI,1·11-1·63) and 1·45% (95%CI,1·11-1·63), respectively. Age, sex, geographical, and occupational factors were not associated with seropositivity (p>0·05). Symptoms and signs within past 3 months and seropositivity were not associated at the time of the survey (p>0·05). INTERPRETATION: SARS-CoV-2 seroprevalence in Mongolia was low in the first year of the pandemic potentially due to strong public health measures, including border restrictions, educational facilities closure, earlier adoption of mask-wearing and others. Our findings suggest large-scale community transmission could not have occurred up to November 2020 in Mongolia. Additional serosurveys are needed to monitor the local pandemic dynamic and estimate how far from herd immunity Mongolia will be following-up with vaccination programme in 2021 and 2022. FUNDING: World Health Organisation, WHO UNITY Studies initiative, with funding by the COVID-19 Solidarity Response Fund and the German Federal Ministry of Health (BMG) COVID-19 Research and development. TRANSLATION: Cyrillic and Traditional Mongolian translation of abstract is available on appendix section.Scopus© Citations 14